XPH Holdings Information

XPH is an equity ETF with a total of 60 individual holdings. The top holdings are Enliven Therapeutics stock at 2.59%, Organon & Co. at 2.43%, Corcept Therapeutics at 2.42%, Definium Therapeutics at 2.26%, and Nektar Therapeutics at 2.25%.

Total Holdings

Top 10 Percentage

22.47%

Asset Class

Equity

ETF Category

Health

Assets

364.82M

PE Ratio

16.73

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ELVN	Enliven Therapeutics, Inc.	2.59%	207,489
2	OGN	Organon & Co.	2.43%	995,305
3	CORT	Corcept Therapeutics Incorporated	2.42%	188,795
4	DFTX	Definium Therapeutics, Inc.	2.26%	341,920
5	NKTR	Nektar Therapeutics	2.25%	86,869
6	PRGO	Perrigo Company plc	2.15%	649,332
7	TRVI	Trevi Therapeutics, Inc.	2.15%	533,501
8	AMLX	Amylyx Pharmaceuticals, Inc.	2.10%	426,652
9	AXSM	Axsome Therapeutics, Inc.	2.07%	39,938
10	MBX	MBX Biosciences, Inc.	2.05%	216,602
11	OMER	Omeros Corporation	2.05%	533,942
12	TERN	Terns Pharmaceuticals, Inc.	2.04%	136,169
13	HRMY	Harmony Biosciences Holdings, Inc.	2.01%	221,254
14	PCRX	Pacira BioSciences, Inc.	2.01%	279,016
15	NUVB	Nuvation Bio Inc.	1.99%	1,387,795
16	JAZZ	Jazz Pharmaceuticals plc	1.95%	34,357
17	RPRX	Royalty Pharma plc	1.92%	136,431
18	VTRS	Viatris Inc.	1.91%	455,975
19	HROW	Harrow, Inc.	1.90%	172,440
20	INVA	Innoviva, Inc.	1.89%	284,122
21	CRNX	Crinetics Pharmaceuticals, Inc.	1.88%	172,259
22	LGND	Ligand Pharmaceuticals Incorporated	1.87%	28,790
23	ANIP	ANI Pharmaceuticals, Inc.	1.85%	83,493
24	INDV	Indivior PLC	1.83%	194,032
25	OCUL	Ocular Therapeutix, Inc.	1.83%	670,526

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Apr 23, 2026